Clinical Trial Update: Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating cinacalcet for treating hypercalcemia and secondary hyperparathyroidism in renal transplant recipients was terminated, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Secondary Hyperparathyroidism, Hypercalcemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-04-29